Detection of minimal residual disease in acute myeloid leukaemia: Methodologies, clinical and biological significance

British Journal of Haematology

Volumn 106, Issue 3, 1999, Pages 578-590

  Liu Yin, John A ^a   Tobal, Khalid ^a  

^a NONE

Author keywords

AML; Detection; Monitoring; MRD; RT PCR

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; CANCER DIAGNOSIS; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ACUTE DISEASE; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM, RESIDUAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 0032878343     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01522.x     Document Type: Review

References (119)

1. Adriaansen, H.J., Jacobs, B.C., Kappers-Klune, M.C., Hahlem, K., Hooijkass, H. & van Dongen, J.J. (1993) Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers. Leukemia, 7, 472-481.
2. Asou, N., Adachi J., Tamura, J., Kanamuru, S., Kageyama, S., Hiraki, A., Omoto, E., Akiyama, H., Tsubaki, K., Saito, K., Kuriyama, K.O.H., Kitano, K., Miyawaki, S., Takeyama, K., Yamada, O., Nishikav, K., Takahashi, M., Matsuda, S., Ohtake, S., Suzushima, H., Emi, I., Ohno, R., for the Japan Adult Leukaemia Study Group (1998) Analysis of prognostic factors in newly diagnosed acute promyelocytic leukaemia treated with all-trans retinoic acid and chemotherapy. Clinical Oncology, 16, 78-85.
3. Austin, S.J., Robinson, L.G., Owen-Jones, C.E., Mills, K.I. & Burnett, A.K. (1998) Real-time PCR (lightcycler technology) for quantitation of AML-ETO fusion transcripts in t(8;21) positive AML. Blood, 92, (Suppl. 1), 75a (abstract 305).
4. Avvisati, G., Lo Coco, F., Diverio, D., Falda, M., Ferrara, F., Lazzari, M., Russo, D., Petti, M.M. & Mandelli, F. (1996) AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a GIMEMA pilot study. Blood, 88, 1390-1398.
5. Avvisati, G., ten Cate, J.W. & Mandelli, F. (1992) Acute promyelocytic leukaemia. British Journal of Haematology, 81, 315-320.
6. Bergmann, L., Miething, C., Maurer, U., Brieger, J., Karakas, T., Weidmann, E. & Hoelzer, D. (1997) High levels of Wilms' tumour gene (wt l) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood, 90, 1217-1225.
7. Betts, D.R., Rohatiner, A.Z.S., Evans, M.L., Rassam, S.M.B., Lister, T.A. & Gibbons, B. (1992) Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature. Leukemia, 6, 1250-1256.
8. Biernaux, C., Loos, M., Sels, A., Huez, G., & Stryckmans, P. (1995) Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood, 86, 3118-3122.
9. Biondi, A., Rambaldi, A., Pandolli, P.P., Rossi, V., Giudici, G., Alcaray, M., Lo Coco, F., Diverio, D., Pogliani, E.M., Lanzi, E.M., Mandelli, F., Masera, G., Barbui, T. & Pelicci, P.G. (1992) Molecular monitoring of the MYL/RARAα fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood, 80, 492-497.
10. Bories, D., Dumont, V., Belhadj, K., Bernaudin, F., Raffi, H., Kuentz, M., Cordonnier, C. & Tulliez, M. (1998) Real-time quantitative RT-PCR monitoring of chronic myelogenous leukemia. Blood, 92, (Suppl. 1), 73a (abstract 296).
11. Borrow, J., Goddard, A.D., Gibbons, B., Katz, F., Swirksy, D., Floretos, T., Dube, L., Winfield, D.A., Kingston, J., Hagemeijer, A., Rees, J.K.H., Lister, T.A. & Solomon, E. (1992) Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts. British Journal of Haematology, 82, 529-540.
12. Bose, S., Deininger, M., Gora-Tybor, J., Goldman, J.M. & Melo, J.V. (1998) The presence of typical and atypical BCR-ABL fusion genes in leucocytes of normal individuals: biological significance and implications for the assessment of minimal residual disease. Blood, 92, 3362-3367.
13. Brenner, M.K., Rill., D.R., Moen, R.C., Krance, R.A., Mirro, J., Jr, Anderson, W.F. & Ihle, J.N. (1993) Gene marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet, 341, 85-86.
14. Burnett, A.K., Goldstone, A.H., Gray, R.G., Wheatley, K., on behalf of the UL MRC Adult Leukaemia Working Party (1997) All-trans retinoic acid given concurrently with induction chemotherapy improves the outcome of APL: results of the UK MRC ATRA trial. Blood, 90, (Suppl. 1), 330a (abstract 1474).
15. Campana, D., Coustan-Smith, E. & Janossy, G. (1990) The immunologic detection of minimal residual disease in acute leukemia. Blood, 76, 163-171.
16. Campana, D. & Pui, C.H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 85, 1416-1434.
17. Chang, K.S., Lu, J., Wang, G., Trujillo, J.M., Estey, E., Cork, A., Chu, D.I., Freireich, E.J. & Stass, S.A. (1992) The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by polymerase chain reaction. Blood, 79, 554-558.
18. Claxton, D.F., Liu, P., Hsu, H.B., Marlton, P., Hester, J., Collins, F., Deisseroth, A.B., Rowley, J.D. & Siciltana, N.J. (1994) Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood, 83, 1750-1756.
19. + malignant myeloblasts has implications for minimal residual disease in acute myeloid leukemia. Leukemia, 7, 853-856.
20. Cross, N.C.P. (1995) Quantitative PCR techniques and applications. British Jounal of Haematology, 89, 693-697.
21. Cross, N.C.P., Feng, L., Chase, A., Bungey, J., Hughes, T.P. & Goldman. J.M. (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood, 82, 1929-1936.
22. De The, H., Chomienne, C., Lanotte, M., Degos, L. & Dejean, A. (1990) The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature, 347, 558-561.
23. Diverio, D., Pandolfi, P.P., Biondi, A., Avvisati, G., Petti, M.C., Mandelli, F., Pelicci, P.G. & Lo Coco, F. (1993) Absence of RT-PCR detectable residual disease in acute promyelocytic leukemia in long-term remission. Blood, 85, 3556-3559.
24. Diverio, D., Pandolfi, P.P., Rossi, V., Biondi, A., Pelicci, P.G. & Lo Coco, F. (1994) Monitoring of treatment outcome in acute promyelocytic leukemia. Leukemia, 10, 1214-1216.
25. Diverio, D., Riccioni, R., Mandelli, F. & Lo Coco, F. (1995) The PML-RARA fusion gene in the diagnosis and monitoring of acute promyelocytic leukaemia. Haematologica, 80, 155-160.
26. Diverio, D., Rossi, V., Avvisati, G., De Santis, S., Pistilli, A., Pane, F., Saglio, G., Martinelli, G., Petti, M.C., Santoro, A., Pelicci, P.G., Mandelli, F., Biondi, A. & Lo Coco, F. (1998) Early detection of relapse by prospective reverse transcriptase polymerase chain reaction analysis of the PML-RARA fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter 'AIDA' trial. Blood, 92, 784-789.
27. Downing, J.R., Head, D.R., Curcio-Brint, A.M., Hulshof, M.G., Motroni, T.A., Raimondi, S.C., Carrol, A.J., Drabkin, H.A., Willman, C., Theil, K.S., Civin, C.I. & Erickson, P. (1993) An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translation. Blood, 81, 2860-2865.
28. El-Rifai, W., Ruutu, T., Elonen, E., Volin, L. & Knuutila, S. (1997) Prognostic value of metaphase-fluorescence in situ hybridisation in follow-up of patients with acute myeloid leukemia in remission. Blood, 89, 3330-3334.
29. Erickson, P., Gao, J., Change, K.S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J.D. & Drabkin, H. (1992) Identification of breakpoints in t(8;21) AML and isolation of a fusion transcript with similarity to Drosophila segmentation gene runt. Blood, 80, 1825-1831.
30. Evans, P.A.S., Short, M.A., Jack, A.S., Norfolk, D.R., Child, J.A., Shiach, C.R., Davies, F., Tobal, K., Liu Yin, J.A. & Morgan, G.J. (1997) Detection and quantitation of the CBFB/MTH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML. Leukemia, 11, 365-369.
31. Frankel, S.R., Eardley, A., Heller, G., Berman, E., Miller, W.H., Jr. Dmitrovsky, E. & Warrell, R.P., Jr (1995) All-trans retinoic acid for acute promyelocytic leukemia: results of the New York study. Annals of Internal Medicine, 120, 278-286.
32. Freireich, E.J., Cork, A., Stass, S.A., McCredie, K.B., Keating, M.J., Estey, E.H., Kantarjian, H.M. & Trujillo, J.M. (1992) Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. Leukemia, 6, 500-506.
33. Fukutani, H., Naoe, T., Ohno, R., Yoshída, H., Kiyoi, S., Miyawaki, S., Morishita, H., Sano, F., Kamibayashi, H., Matsue, K., Miyake, T., Hasegawa, A., Ueda, Y., Kato, Y., Kobayashi, H., Shimazaki, C., Kobayashi, M., Kurane, R., Sakota, H., Masaki, K., Wakayama, T., Tohyama, K., Nonaka, Y. & Notori, H. (1995) Prognostic significance of the RT-PCR assay of PML/RARα transcripts in acute promyelocytic leukemia. Leukemia, 9, 588-593.
34. Gallagher, R.E., Li, Y.P., Rao, S., Paitta, E., Anderson, J., Etkind, P., Bennett, J.M., Tallman, M.S. & Wiernik, P.H. (1995) Characterisation of acute promyelocytic leukemia cases with PML/RARA break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood, 86, 1540-1547.
35. Gessler, M., Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H. & Bruns, G.A. (1990) Homozygous deletion in Wilms: tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343, 774-778.
36. Gibson, V.E., Heid, C.A. & Williams, P.M. (1996) A novel method for real-time quantitative RT-PCR. Genome Research, 6, 995-1001.
37. Goldie, J. & Coldman, A. (1985) Genetic instability in the development of drug resistance. Seminars in Oncology, 12, 222-230.
38. Gray, J.W., Kuo, W.L. & Liang, J. (1990) Analytical approaches to detection and characterisation of disease-linked chromosome aberrations. Bone Marrow Transplantation, 6, 14-19.
39. Greaves, M. (1997) Silence of the leukemic clone. New England Journal of Medicine, 336, 367-369.
40. + T lymphocytes in mobilised peripheral blood of t(8;21) AML M2 in complete remission. Blood, 88, (Suppl. 1), 562a (abstract 2238).
41. Grignani, F., Fagliolo, M., Ferrucci, P.F., Alcalay, M. & Pelicci, P.G. (1993) The molecular genetics of acute promyelocytic leukemia. Blood Reviews, 7, 87-93.
42. Grimwade, D., Howe, K., Langabeer, S., Burnett, A.K., Goldstone, A. & Solomon, E. (1996) Minimal residual disease detection in acute promyelocytic leukemia by reverse transcriptase PCR: evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse. Leukemia, 10, 61-66.
43. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A. & Goldstone, A. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. Blood, 92, 2322-2333.
44. Hagenbeek, A. & Martens, A.C.M. (1991) Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML). Balliere's Clinical Haematology, 4, 609-635.
45. Hart, J.S., Trujillo, J.M., Freireich, E.J., George, S.L. & Frei, E., III (1971) Cytogenetic studies and their clinical correlates in adults with acute leukaemia. Annals of Internal Medicine, 75, 353-360.
46. Hebert, J., Cayuela, J.M., Daniel, M.T., Berger, R. & Sigaux, F. (1994) Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification. Blood, 84, 2291-2296.
47. Heid, C.A., Stevens, J., Livak, K.J. & Williams, P.M. (1996) Real-time quantitative PCR. Genome Research, 6, 986-994.
48. Higuchi, R., Dollinger, G., Walsh, P.S. & Griffith, R. (1992) Simultaneous amplification and detection of specific DNA sequences. Biotechnology, 10, 413-417.
49. Higuchi, R., Fockler, C., Dollinger, G. & Watson, R. (1993) Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology, 11, 1026-30.
50. Holland, P.M., Abramson, R.D., Watson, R., Gelfand, D.H. (1991) Detection of specific polymerase chain reaction product by utilising the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proceedings of the National Academy of Sciences of the United States of America, 88, 7276-80.
51. Huang, W., Sun, G-L, Li, X-S. Cao, Q., Lu, Y., Jang, G-S, Znang, F-Q, Chai, J-R, Wang, Z-Y, Waxman, S., Chen, Z. & Chen, S.-J. (1993) Acute promyelocytic leukemia: clinical relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotranscriptase polymerase chain reaction. Blood, 82, 1264-1269.
52. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K., Jyi, T., Dhoy, H., Nakauchi, H., Ishidate, T., Akiyama, T. & Kishimoto, T. (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood, 84, 3071-3079.
53. Inoue, K., Ogawa, H., Yamagami, T., Soma, T., Tani, Y., Tatekawa, Y., Oji, Y., Tamaki, H., Kyo, T., Dohy, H., Hiraoka, A., Masaoka, T., Kishimoto, T. & Sugiyama, H. (1996) Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms' tumor gene) expression levels. Blood, 88, 2267-2278.
54. Jacobs, P. (1977) Discrepant bone marrow aspirations in leukaemia. Lancet, ii, 355-356.
55. Jurlander, J., Caligiuri, M.A., Ruutu, T., Baer, M.R., Strout, M.P., Oberkircher, A.R., Hoffman, L., Ball, E.D., Freilahr, D.A., Christiansen, N.P., Block, A.M., Knuutila, S., Herzig, G.P. & Bloomfield, C.D. (1996) Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood, 88, 2183-2191.
56. Kakizuka, A., Miller, W.H., Jr. Umesono, K., Warrell, R.P., Jr, Frankel, S.R., Murty, V.V.V.S., Dmitrovsky, E. & Evans, R.M. (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukaemia fuses RARα with a novel putative transcription factor, PML. Cell, 66, 663-674.
57. Korninger, L., Knobl, P., Laczika K., Mustala, S., Quehenberger, P., Schwarzinger, I., Lechner, K., Jaeger, U. & Mannhalter, C. (1994) PML/RARα PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2-3 months. British Journal of Haematology, 88, 427-431.
58. Krauter, J., Wattjes, M., Nagel, S., Aedenreich, O., Bunjes, D., Bergmann, L., Heil, G. & Ganser, A. (1998) AML1/MTG8 Real Time RT-PCR for the detection of minimal residual disease in patients with t(8;21) positive AML. Blood, 92, (Suppl. 1), 74a (abstract 304).
59. Kreuzer, K.A., Lass, U., Nagel, S., Ellerbrok, H., Pauli, G., Hohn, D. & Schmidt, C.A. (1998) Absolute quantitative BCR-ABL RT-PCR for the molecular monitoring of CML patients. Blood, 92, (Suppl. 1), 72a (abstract 295).
60. Kusec, R., Laczika, K., Knobl, P., Freidl, J., Greinix, H., Kahls, P., Linkesch, W., Schwarzinger, I., Mitterbauer, G., Purtscher, B., Haas, O., Lechner, K. & Jaeger, U. (1994) AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia, 8, 735-739.
61. Kwong, Y.L., Chan, V., Wong, K.F. & Chan, T.K. (1995) Use of polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21). Cancer, 75, 821-825.
62. Lackzika, K., Mitterbauer, G., Korninger, L., Knobl, P., Scharzinger, I., Kapiotis, S., Haas, O.A., Kyrle, P.A., Pont, J. & Ochler, L. (1994) Rapid achievements of PML/RARA PCR negativity by combined treatment with all-trans retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study. Leukemia, 8, 1-5.
63. Langabeer, S.E., Walker, H., Gale, R.E., Wheatley, K., Burnett, A.K., Goldstone, A.H. & Linch, D.C. (1997a) Frequency of CBFB/ MYH11 fusion transcripts in patients entered into the UK MRC AML trials. British Journal of Haematology, 96, 736-739.
64. Langabeer, S.E., Walker, H., Rogers, J.R., Burnett, A.K., Wheatley, K., Swirsky, D. & Goldstone, A.H. (1997b) Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. British Journal of Haematology, 99, 925-928.
65. Larson, R.A., Williams, S.F., Le Beau, M.M., Bitter, M.A., Vardiman, J.W. & Rowley, J.D. (1986) Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) and t(16;16;) has a favorable prognosis. Blood, 68, 1242-1249.
66. Le Beau, M.M. (1993) Detecting genetic changes in human tumor cells: have scientists 'gone fishing?' Blood, 81, 1979-1983.
67. Le Beau, M.M., Larson, R.A., Bitter, M.A., Vardiman, J.W., Golomb, H.M. & Rowley, J.D. (1983) Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia: a unique cytogenetic-clinicopathological association. New England Journal of Medicine, 309, 630-636.
68. Lee, L.G., Connell, C.R. & Bloch, W. (1993) Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Research, 21, 3761-3766.
69. Lion, T. (1996) Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects. Leukemia, 10, 896-906.
70. Lion, T.D.K. & Kidd, V. (1998) Debate round-table: appropriate controls for RT-PCR. Leukemia, 12, 1983-1993.
71. Liu, P., Hajra, A., Wijmenga, C. & Collins, F.S. (1995) Molecular pathogenesis of the chromosome 16 inversion in the M4E0 subtype of acute myeloid leukemia. Blood, 85, 2289-2302.
72. Liu, P., Tarle, S.A., Hajra, A., Claxton, D.F., Marlton, P., Freedman, M., Siciliano, M.J. & Collins, E.S. (1993) Fusion between transcription factor CBFβ/PEBP 2β and a myosin heavy chain in acute myeloid leukemia. Science, 261, 1041-1044.
73. Lo Coco, F., Diverio, D., Pandolfi, P.P., Biondi, A., Rossi, V., Avvisati, G., Rambaldi, A., Arcese, W., Petti, M.C., Meloni, G., Mandelli, F., Grignani, F., Masera, G., Barbui, T. & Pelicci, P.G. (1992) Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet, 340, 1437-1438.
74. Lo Coco, F., Nervi, C., Avvisati, G. & Mandelli, F. (1998) Acute promyelocytic leukemia: a curable disease. Leukemia, 12, 1866-1880.
75. Macedo, A., Orfao, A., Gonzalez, M., Vidriales, M.B., Lopez-Berges, M.C., Martinez, A. & San Miguel, J.F. (1995) Immunological detection of blast cell subpopulatioins in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies. Leukemia, 9, 993-998.
76. Marcucci, G., Caligiuri, M.A., Oberkircher, A.R. & Bloomfield, C.D. (1997) Absence of MRD by reverse transcription polymerase chain reaction in CBFB/MYH11-associated acute myeloid leukemia. Blood, 90, (Suppl. 1), 62a (abstract 270).
77. Marcucci, G., Livak, K.J., Bi, W., Strout, M.P., Bloomfield, C.D. & Caligiuri, M.A. (1998) Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase reaction assay. Leukemia, 12, 1482-1489.
78. Martens, A.C.M., Schultz, F.W. & Hagenbeek, A. (1987) Non-homogeneous distribution of leukemia in the bone marrow during minimal residual disease. Blood, 70, 1073-1078.
79. Martinet, D., Muhlmatter, D., Leeman, M., Parlier, V., Hess, U., Gmur, J. & Jotterand, M. (1997) Detection of 16p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML). Leukemia, 11, 964-970.
80. Miller, W.H., Jr, Levine, K., DeBlasio, A., Frankel, S.R., Dmitrovsky, E. & Warrell, J.R. (1993) Detection of minimal residual disease in acute promyelocytic leukemia by reverse transcriptase polymerase chain reaction assay for PML-RARα fusion mRNA. Blood, 82, 1689-1694.
81. Miwa, H., Beran, M. & Saunders, G.F. (1992) Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia, 6, 405-409.
82. Miyamoto, T., Nagafuji, K., Akashi, K., Harada, M., Kyo, T., Akashi, T., Takenaka, K., Mizuno, S., Gondo, H., Okamura, T., Dohy, K. & Niho, Y. (1996) Persistence of multipotent progenitors expressing AML 1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood, 87, 4789-4796.
83. - cytotoxic T-cell clones specific for leukemia blasts in children with acute leukemia. Cancer Research, 55, 3835-3839.
84. Morschhauser, F., Cayuela, J.M., Martini, S., Baruchel, A., Rousselot, P., Socie, G., Berthou, P., Jovet, J.P., Straetmans, N., Fenaux, P. & Preudhomme, C. (1998) Evaluation of minimal residual disease using RT-PCR in t(8;21) AML: a multicentre study on 50 patients. Blood, 92, (Suppl. 1), 75a (abstract 306).
85. Muto, A., Mori, S., Matsushita, H., Awaya, N., Ueno, H., Takayama, N., Okamoto, S., Kizaki, M. & Ikeda, Y. (1996) Serial quantitation of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay. British Journal of Haematology, 95, 85-94.
86. Newton, J., Tobal, K. & Liu Yin, J.A. (1997) Peripheral blood as well as bone marrow samples can be used for the quantitation of AML1-MTG8 transcripts to assess effectiveness of treatment and predict relapse. British Journal of Haematology, 97, (Suppl. 1), 3.
87. Nucifora, G., Birn, D.J., Erickson, P., Gao, J., Le Beau, M.M., Drabkin, H.A. & Rowley, J.D. (1993a) Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood, 81, 883-888.
88. Nucifora, G., Larson, R.A. & Rowley, J.D. (1993b) Persistance of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood, 82, 712-715.
89. Perego, R.A., Marenco, P., Bianchi, C., Cairoli, R., Urbano, M., Nosari, A.M., Muti, G., Morra, E. & Del Monte, U. (1996) PML/ RARα transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation. Leukemia, 10, 207-212.
90. Peruzzi, D., DeBlasio, T. & Warrell, P.P. (1996) Highly sensitive RT-PCR assay for detection of minimal residual disease in APL. Blood, 98, (Suppl. 1), 366a (abstract 1452).
91. Pignon, J.M., Henni, T., Amselem, S., Vidaud, M., Duquesnoy, P., Vernant, J.P., Keuntz, M., Cordonnier, C., Rochant, H. & Goossens, M. (1990) Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia, 4, 83-86.
92. Poirel, H., Radford-Weiss, I., Rack, K., Troussard, X., Veil, A., Valensi, F., Picard, F., Guesnu, M., Leboeuf, D., Melle, J., Dreyfus, F., Flandrin, G. & Macintyre, E. (1995) Detection of the chromosome 16 CBFB-MYH11 fusion transcript in myelomonocytic leukemias. Blood, 85, 1313-1322.
93. Potter, M.N., Steward, G.G., Maitland, N.J. & Oakhill, A. (1992) Detection of clonality in childhood B-lineage acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia, 6, 289-294.
94. Pratt, W.B., Ruddon, R.W., Ensminger, W.D. & Maybaum, J. (1994) Determination of drug responsiveness. The Anticancer Drugs, pp. 20-42. Oxford University Press, New York.
95. Radich, J.P., Gehly, G., Gooley, T., Bryant, E., Clift, R.A., Collins, S., Edmonds, S., Kirk, J., Lee, A., Kessler, G., Schoch, G., Buckner, C.D., Sullivan, K.M., Applebaum, F.R. & Thomas, E.D. (1995) Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplants for chronic myeloid leukemia: results and implications in 346 patients. Blood, 85, 2632-2638.
96. Reading, C.L., Estey, E.H., Huh, Y.O., Claxton, D.F., Sanchez, G., Terstappen, L.W.M.M., O'Brien, M.C., Baron, S. & Deisseroth, A.B. (1993) Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood, 81, 3083-3090.
97. Roberts, W.M., Estrov, Z., Ouspenskaia, M.V., Johnson, D.A., McClain, K.L. & Zipf, T.F. (1997) Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. New England Journal of Medicine, 3336, 317-323.
98. Roman, J., Martin, C., Torres, A., Jimenez, M.A., Andres, O., Flores, R., De la Torre, M.J., Sanchez, J., Serrano, J. & Falcon, M. (1997) Absence of detectable PML/RARα fusion transcripts in long-term remission patients after bone marrow transplantation for acute promyelocytic leukemia. Bone Marrow Transplantation, 17, 679-683.
99. Roth, M.S., Antin, J.H., Bingham, E.L. & Ginsburg, D. (1989) Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood, 74, 882-885.
100. San Miguel, J.F., Martinez, A., Macedo, A., Vidriates, M.B., Lopez-Berges, C., Gonzolez, M., Cabellero, D., Garcia-Marcos, M.A., Ramos, F., Fernandez-Calvo, J., Calmintia, M.J., Diaz-Mediavilla, J. & Orfao, A. (1997) Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood, 90, 2465-2470.
101. Satake, N., Maseki, N., Kozu, T., Sakashita, A., Kobayashi, H., Sakurai, M., Ohki, M. & Kaneko, Y. (1995) Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission. British Journal of Haematology, 91, 892-898.
102. Saunders, J.M., Brereton, M.L., Adams, J.A., Tobal, K. & Liu Yin, J.A. (1997) Expression of AML1-MTG8 transcripts in clonogenic cells grown from bone marrow of patients in remission of acute myeloid leukaemia with t(8;21). British Journal of Haematology, 99, 921-924.
103. Saunders, M.J., Tobal, K. & Liu Yin, J.A. (1994) Detection of t(8;21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukemia type M2 after chemotherapy or bone marrow transplantation. Leukemia Research, 18, 891-895.
104. Secker-Walker, L.M. (1988) Leukaemia Research Fund International Research Symposium: Chromosomes and genes in leukaemia. Leukemia, 2, 176-180.
105. Seale, J.R., Varma, S., Swirsky, D., Pandolfi, P.P., Goldman, J.M. & Cross, N.C.P. (1996) Quantitation of PML-RARA transcripts in APL: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interferon. British Journal of Haematology, 95, 95-101.
106. Sievers, E.L., Lange, B.J., Buckley, J.D., Smith, F.O., Wells, D.A., Daigneault-Creech, C.A., Shutts, R.E., Bernstein, I.D. & Loken, M.R. (1996) Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. Journal of the National Cancer Institute, 88, 1483-1488.
107. Sinclair, P.B., Green, A.R., Grace, C. & Nacheva, E.P. (1997) Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridisation system. Blood, 90, 1395 1402.
108. Smith, M.T., Zhang, L., Wang, Y., Hayes, R.B., Li, G., Wiemels, J., Dosemeci, M., Titenko-Holland, N., Xi, L., Kolachana, P., Yin, S. & Rothman, N. (1998) Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Research, 58, 2176-2181.
109. Swirsky, D.M., Li, Y.S., Matthews, J.G., Flemans, R.J., Rees, J.K.H. & Hayhoe, F.G.J. (1994) (8;21) translocation in acute granutocytic leukaemia: cytological, cytochemical and clinical features. British Journal of Haematology, 56, 199-213.
110. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M. & Wiernik, P.H. (1997) All-trans retinoic acid in acute promyelocytic leukemia. New England Journal of Medicine, 337, 1201-1208.
111. Tanaka, K., Arif, M., Eguchi, M., Kumaravel, T.S., Ueda, R., Ohno, R., Iwato, K., Kyo, T., Dohy, H. & Kamada, N. (1997) Application of fluorescence in situ hybridisation to detect residual leukemic cells with 9;22 and 15;77 translocations. Leukemia, 11, 436-40.
112. Terstappen, L.W.M.M., Safford, M., Konemann, S., Loken, M.R., Zurlutter, K., Buchner, T., Hiddeman, W. & Worman, B. (1992) Flow cytometric characterisation of acute myeloid leukaemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia, 6, 70-80.
113. Testa, J.R., Mintz, U., Rowley, J.D., Vardiman, J. & Golomb, H.M. (1979) Evolution of karyotypes in acute nonlymphocytic leukaemia. Cancer Research, 39, 3619-3627.
114. Tkachuk, D.C., Westbrook, C.A., Andreef, M., Donlon, T.A., Cleary, M.L., Suryanarayan, K., Homge, M., Redner, A., Gray, J. & Pinkel, D. (1990) Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridisation. Science, 250, 559-562.
115. Tobal, K., Johnson, P.R.E., Saunders, M.J., Harrison, C.J. & Liu Yin, J.A. (1995a) Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission. British Journal of Haematology, 91, 104-108.
116. Tobal, K. & Liu Yin, J.A. (1996) Monitoring of minimal residual disease by quantitative reverse transcriptase polymerase chain reaction for AML-MTG8 transcipts in AML-M2 with t(8;21). Blood, 88, 3704-3709.
117. Tobal, K. & Liu Yin, J.A. (1998) RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients with long-term remission of APL. Leukemia, 12, 1349 1354.
118. Tobal, K., Saunders, M.J., Grey, M.R. & Liu Yin, J.A. (1995b) Persistence of RARA-PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long-term remission of acute promyelocytic leukaemia. British Journal of Haematology, 90, 615-618.
119. Van-Lom, K., Haagemeijer, A., Vandekerckhove, F., de-Greef, G.E., Sacchi, N. & Lowenberg, B. (1997) Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): only myeloid cells are part of the malignant clone. Leukemia, 11, 202-205.